A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers.

Narod, S A; Tung, N; Lubinski, J; Huzarski, T; Robson, M; Lynch, H T; Neuhausen, S L; Ghadirian, P; Kim-Sing, C; Sun, P; Foulkes, W D.

Afiliação

Narod SA; Women's College Research Institute, University of Toronto, Toronto, ON.
Tung N; Beth Israel Deaconness Hospital, Boston, MA, U.S.A.
Lubinski J; Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Huzarski T; Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Robson M; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York City, NY, U.S.A.
Lynch HT; Department of Preventive Medicine, Creighton University, Omaha, NE, U.S.A.
Neuhausen SL; Beckman Research Institute of the City of Hope, Duarte, CA, U.S.A.
Ghadirian P; Epidemiology Research Unit, CHUM-Hôtel-Dieu, Montreal, QC.
Kim-Sing C; BC Cancer Agency, Vancouver, BC.
Sun P; Women's College Research Institute, University of Toronto, Toronto, ON.
Foulkes WD; Departments of Medical Genetics and Oncology, McGill University, Montreal, QC.